The Cancer Letter

Inside information on cancer research and drug development

Vol.
28
No.
4
April 29, 2005Apr 29, 2005
Free
DOWNLOAD THE PDF

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

Avastin Improves PFS In Advanced Breast Cancer

Preoperative Drug Combo Benefits HER-2 Breast Cancer

Combination Radiation/Vaccine May Benefit Some Patients

“Inoperable” Prostate Cancer May Be Operable, Curable

Benefit Seen In Novel Drug That Treats Gleevec Resistance

NCI’s Rosenberg Confirms 2002 Immunotherapy Results

NCI-Approved Clinical Trials

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account